STT3A
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
Also known as: ITM1, MGC9042, STT3-A, STT3A_HUMAN, TMC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46977
- Gene
- STT3A
- Ensembl
- ENSG00000134910
- Chromosome
- 11
- Canonical length
- 705 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is a catalytic subunit of the N-oligosaccharyltransferase (OST) complex, which functions in the endoplasmic reticulum to transfer glycan chains to asparagine residues of target proteins. A separate complex containing a similar catalytic subunit with an overlapping function also exists. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
Canonical amino-acid sequenceUniProt
705 residues, UniProt reviewed canonical sequence.
>P46977|STT3A
1 MTKFGFLRLS YEKQDTLLKL LILSMAAVLS FSTRLFAVLR FESVIHEFDP YFNYRTTRFL
61 AEEGFYKFHN WFDDRAWYPL GRIIGGTIYP GLMITSAAIY HVLHFFHITI DIRNVCVFLA
121 PLFSSFTTIV TYHLTKELKD AGAGLLAAAM IAVVPGYISR SVAGSYDNEG IAIFCMLLTY
181 YMWIKAVKTG SICWAAKCAL AYFYMVSSWG GYVFLINLIP LHVLVLMLTG RFSHRIYVAY
241 CTVYCLGTIL SMQISFVGFQ PVLSSEHMAA FGVFGLCQIH AFVDYLRSKL NPQQFEVLFR
301 SVISLVGFVL LTVGALLMLT GKISPWTGRF YSLLDPSYAK NNIPIIASVS EHQPTTWSSY
361 YFDLQLLVFM FPVGLYYCFS NLSDARIFII MYGVTSMYFS AVMVRLMLVL APVMCILSGI
421 GVSQVLSTYM KNLDISRPDK KSKKQQDSTY PIKNEVASGM ILVMAFFLIT YTFHSTWVTS
481 EAYSSPSIVL SARGGDGSRI IFDDFREAYY WLRHNTPEDA KVMSWWDYGY QITAMANRTI
541 LVDNNTWNNT HISRVGQAMA STEEKAYEIM RELDVSYVLV IFGGLTGYSS DDINKFLWMV
601 RIGGSTDTGK HIKENDYYTP TGEFRVDREG SPVLLNCLMY KMCYYRFGQV YTEAKRPPGF
661 DRVRNAEIGN KDFELDVLEE AYTTEHWLVR IYKVKDLDNR GLSRTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STT3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 13
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 369 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 369 nTPM
- epididymis: 133 nTPM
- cervix: 80 nTPM
- thyroid gland: 79 nTPM
- salivary gland: 76 nTPM
- seminal vesicle: 73 nTPM
Single-cell type
- plasma cells: 109 nCPM
- extravillous trophoblasts: 98 nCPM
- endometrial glandular cells: 73 nCPM
- lacrimal acinar cells: 65 nCPM
- syncytiotrophoblasts: 64 nCPM
- salivary acinar cells: 63 nCPM
Immune cell
- plasmacytoid DC: 159 nTPM
- basophil: 97 nTPM
- MAIT T-cell: 78 nTPM
- myeloid DC: 65 nTPM
- gdT-cell: 56 nTPM
- memory CD4 T-cell: 54 nTPM
Brain region
- choroid plexus: 60 nTPM
- white matter: 44 nTPM
- hypothalamus: 40 nTPM
- medulla oblongata: 39 nTPM
- midbrain: 36 nTPM
- thalamus: 35 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STT3A.
Disease | AllUniProt
Conditions STT3A is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1W, autosomal recessive (CDG1WAR) MIM:615596
- Congenital disorder of glycosylation 1W, autosomal dominant (CDG1WAD) MIM:619714
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 288 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital disorder of glycosylation, type Iw, autosomal dominant
- STT3A-congenital disorder of glycosylation
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 3.62
- DepMap mean gene effect
- -0.25
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- post-translational protein modification
- protein N-linked glycosylation
- protein N-linked glycosylation via asparagine
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Oligosaccharyl transferase, STT3 subunit
- Oligosaccharyl transferase STT3, N-terminal domain
- Oligosaccharyl transferase STT3, N-terminal
- AglB-like, core domain
- AglB core domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STT3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STT3A as an antibody target. Whether an autoantibody or antibody against STT3A could matter depends on whether native STT3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STT3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STT3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...